Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,065,646 papers from all fields of science
Search
Sign In
Create Free Account
XR9576
Known as:
XR 9576
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
tariquidar
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Synthesis and in vivo evaluation of ¹⁸F-fluoroethyl GF120918 and XR9576 as positron emission tomography probes for assessing the function of drug efflux transporters.
K. Kawamura
,
Tomoteru Yamasaki
,
+9 authors
Ming-Rong Zhang
Bioorganic & Medicinal Chemistry
2011
Corpus ID: 206220530
2010
2010
Synthesis and evaluation of [11C]XR9576 to assess the function of drug efflux transporters using PET
K. Kawamura
,
F. Konno
,
+8 authors
Ming-Rong Zhang
Annals of Nuclear Medicine
2010
Corpus ID: 23029831
ObjectiveXR9576 (tariquidar) is an anthranilic acid derivative and potent P-glycoprotein (P-gp) inhibitor. XR9576 has undergone…
Expand
2010
2010
Abstract 3527: A pharmacodynamic study of docetaxel in combination with the p-glycoprotein antagonist, tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer
R. Kelly
,
R. Robey
,
+8 authors
S. Bates
2010
Corpus ID: 72138390
Purpose: P-glycoprotein (Pgp) antagonists have been difficult to develop because of complex pharmacokinetic interactions and a…
Expand
2010
2010
Analysis of P-glycoprotein structure and binding sites
Y. Dai
,
Feng Zhang
,
N. Chen
,
Guoliang Wang
,
S. Jia
,
Heng Zheng
International Conference on Information Science…
2010
Corpus ID: 17158834
Multidrug resistance is one of the major causes for the failure to successful chemotherapy. Although there are many mechanisms…
Expand
2006
2006
In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2).
P. Labrie
,
Shawn P. Maddaford
,
+4 authors
R. Gaudreault
Bioorganic & Medicinal Chemistry
2006
Corpus ID: 8982000
2006
2006
In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity at CYP-450.
P. Labrie
,
Shawn P. Maddaford
,
+4 authors
R. Gaudreault
Bioorganic & Medicinal Chemistry
2006
Corpus ID: 24053966
Synthesis and in vitro cytotoxicity assays of new anthranilamide MDR modulators have been performed to assess their inhibition…
Expand
2003
2003
Optimizing chemotherapy by measuring reversal of P-glycoprotein activity in plasma membrane vesicles.
S. Köhler
,
W. Stein
Biotechnology and Bioengineering
2003
Corpus ID: 31361130
The appearance of multidrug resistance (MDR) of cancer cells is a major obstacle to successful chemotherapy. Several proteins…
Expand
Highly Cited
2003
Highly Cited
2003
Pumping of Drugs by P-Glycoprotein: A Two-Step Process?
T. Litman
,
T. Skovsgaard
,
W. Stein
Journal of Pharmacology and Experimental…
2003
Corpus ID: 6953448
The apparent inhibition constant, Kapp, for the blockade of P-glycoprotein (P-gp) by four drugs, verapamil, cyclosporin A, XR9576…
Expand
2003
2003
JPET # 56960 Page 2 RUNNING TITLE PAGE Running title : Two-step pumping by P-glycoprotein
T. Litman
,
T. Skovsgaard
,
W. Stein
2003
Corpus ID: 36490651
The apparent inhibition constant, Kapp, for the blockade of P-glycoprotein (P-gp) by four drugs, verapamil, cyclosporin A, XR9576…
Expand
2001
2001
In Vitro and in Vivo Reversal of P-Glycoprotein-mediated Multidrug Resistance by a Novel Potent Modulator , XR 9576
2001
Corpus ID: 21453389
The overexpression of P-glycoprotein (P-gp) on the surface of tumor cells causes multidrug resistance (MDR). This protein acts as…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required